233 related articles for article (PubMed ID: 34239928)
21. Matched case-control analysis of polymicrobial bloodstream infection in a neonatal intensive care unit.
Bizzarro MJ; Dembry LM; Baltimore RS; Gallagher PG
Infect Control Hosp Epidemiol; 2008 Oct; 29(10):914-20. PubMed ID: 18808341
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics and risk factors of polymicrobial Staphylococcus aureus bloodstream infections.
Zheng C; Zhang S; Chen Q; Zhong L; Huang T; Zhang X; Zhang K; Zhou H; Cai J; Du L; Wang C; Cui W; Zhang G
Antimicrob Resist Infect Control; 2020 May; 9(1):76. PubMed ID: 32460851
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics, risk factors, and outcomes of patients with polymicrobial Pseudomonas aeruginosa bloodstream infections.
Zheng C; Wang G; Qiu L; Luo X; Zhang X; Zhong L; Zhang C; Lin R; Chen Q
J Chin Med Assoc; 2023 Dec; 86(12):1066-1073. PubMed ID: 37792994
[TBL] [Abstract][Full Text] [Related]
24. Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey.
Trecarichi EM; Pagano L; Martino B; Candoni A; Di Blasi R; Nadali G; Fianchi L; Delia M; Sica S; Perriello V; Busca A; Aversa F; Fanci R; Melillo L; Lessi F; Del Principe MI; Cattaneo C; Tumbarello M;
Am J Hematol; 2016 Nov; 91(11):1076-1081. PubMed ID: 27428072
[TBL] [Abstract][Full Text] [Related]
25. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae.
Falcone M; Bassetti M; Tiseo G; Giordano C; Nencini E; Russo A; Graziano E; Tagliaferri E; Leonildi A; Barnini S; Farcomeni A; Menichetti F
Crit Care; 2020 Jan; 24(1):29. PubMed ID: 32000834
[TBL] [Abstract][Full Text] [Related]
26. Polymicrobial Bacteremia Involving
Liu Q; Wu J; Wang Z; Wu X; Wang G; Ren J
Surg Infect (Larchmt); 2019; 20(4):317-325. PubMed ID: 30735082
[No Abstract] [Full Text] [Related]
27. Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study.
Giacobbe DR; Del Bono V; Trecarichi EM; De Rosa FG; Giannella M; Bassetti M; Bartoloni A; Losito AR; Corcione S; Bartoletti M; Mantengoli E; Saffioti C; Pagani N; Tedeschi S; Spanu T; Rossolini GM; Marchese A; Ambretti S; Cauda R; Viale P; Viscoli C; Tumbarello M;
Clin Microbiol Infect; 2015 Dec; 21(12):1106.e1-8. PubMed ID: 26278669
[TBL] [Abstract][Full Text] [Related]
28. Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae.
Anderson DJ; Engemann JJ; Harrell LJ; Carmeli Y; Reller LB; Kaye KS
Antimicrob Agents Chemother; 2006 May; 50(5):1715-20. PubMed ID: 16641440
[TBL] [Abstract][Full Text] [Related]
29. [Impact of extended-spectrum β-lactamase on clinical outcome and medical cost in patients with bloodstream infection due to Klebsiella pneumoniae].
Li JQ; Tang CQ; Wang H; Ji SZ; Lü KY; Xiao SC; Deng AM; Huang Y; Xia ZF
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1903-6. PubMed ID: 27373357
[TBL] [Abstract][Full Text] [Related]
30. Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections.
Viale P; Giannella M; Lewis R; Trecarichi EM; Petrosillo N; Tumbarello M
Expert Rev Anti Infect Ther; 2013 Oct; 11(10):1053-63. PubMed ID: 24073806
[TBL] [Abstract][Full Text] [Related]
31. Risk factors and outcomes for carbapenem-resistant Klebsiella pneumoniae bacteremia in onco-hematological patients.
Liu J; Wang H; Huang Z; Tao X; Li J; Hu Y; Dou Q; Zou M
J Infect Dev Ctries; 2019 May; 13(5):357-364. PubMed ID: 32053504
[TBL] [Abstract][Full Text] [Related]
32. Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors.
Amit S; Mishali H; Kotlovsky T; Schwaber MJ; Carmeli Y
Clin Microbiol Infect; 2015 Jan; 21(1):30-4. PubMed ID: 25636924
[TBL] [Abstract][Full Text] [Related]
33. Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study.
Orsi GB; Bencardino A; Vena A; Carattoli A; Venditti C; Falcone M; Giordano A; Venditti M
Infection; 2013 Feb; 41(1):61-7. PubMed ID: 23070604
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of
Tian L; Tan R; Chen Y; Sun J; Liu J; Qu H; Wang X
Antimicrob Resist Infect Control; 2016; 5():48. PubMed ID: 27891222
[TBL] [Abstract][Full Text] [Related]
35. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
[TBL] [Abstract][Full Text] [Related]
36. Clinical and Bacterial Characteristics of
Wu X; Shi Q; Shen S; Huang C; Wu H
Front Cell Infect Microbiol; 2021; 11():688989. PubMed ID: 34604103
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics, risk factors and outcomes of mixed Candida albicans/bacterial bloodstream infections.
Zhong L; Zhang S; Tang K; Zhou F; Zheng C; Zhang K; Cai J; Zhou H; Wang Y; Tian B; Zhang Z; Cui W; Dong Z; Zhang G
BMC Infect Dis; 2020 Nov; 20(1):810. PubMed ID: 33158426
[TBL] [Abstract][Full Text] [Related]
38. Clinical predictors and outcome impact of community-onset polymicrobial bloodstream infection.
Yo CH; Hsein YC; Wu YL; Hsu WT; Ma MH; Tsai CH; Chen SC; Lee CC
Int J Antimicrob Agents; 2019 Dec; 54(6):716-722. PubMed ID: 31560960
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study.
Giannella M; Graziano E; Marconi L; Girometti N; Bartoletti M; Tedeschi S; Tumietto F; Cristini F; Ambretti S; Berlingeri A; Lewis RE; Viale P
Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1965-1970. PubMed ID: 28567543
[TBL] [Abstract][Full Text] [Related]
40. New options for bloodstream infections caused by colistin- or ceftazidime/avibactam-resistant Klebsiella pneumoniae.
Yu W; Luo Q; Shen P; Chen Y; Xu H; Xiao Y; Qiu Y
Int J Antimicrob Agents; 2021 Dec; 58(6):106458. PubMed ID: 34706255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
